Bempedoic acid vs statins for cholesterol in people who struggle with statins
Treatments studied
Part of Heart & circulation clinical trials.
This trial tests a new medicine called bempedoic acid compared to statins for people who have trouble sticking with statins. It looks at how well each medicine lowers 'bad' cholesterol and how well they are tolerated.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 40 years old or older.
- You have never had a heart attack, stroke, or serious heart or blood vessel problem.
- Your 'bad' cholesterol (LDL) is 130 or higher, or your doctor says you have a high risk of heart disease (7.5% or more over 10 years).
- You have had trouble taking statin medications (for example, missing doses or stopping because of side effects).
- You are not pregnant, breastfeeding, or planning to become pregnant; if you could become pregnant, you must use reliable birth control.
- You are not currently taking certain other cholesterol medicines (like PCSK9 inhibitors, fibrates, or niacin).
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a drug called bempedoic acid to see if it can safely help lower cholesterol in adults. It may be an option if you have high cholesterol and need a different treatment.
This study tests whether bempedoic acid, a new cholesterol-lowering medication, can help people with heart disease or very high cholesterol. You'd take it along with your current cholesterol medications to see if it further reduces your cholesterol levels and protects your heart.
This study observes patients with high cholesterol or mixed lipid disorders who are taking bempedoic acid, alone or with ezetimibe, to see how it works in real life. It aims to gather information that may help doctors better manage cholesterol.
This study tests adding a newer cholesterol-lowering pill (bempedoic acid) to usual care for people who have been recently hospitalized for a heart event. It aims to see if the combination helps lower cholesterol better than standard medicines alone.
This study compares two new medicines—obicetrapib and bempedoic acid—to see which one better lowers cholesterol in people whose cholesterol remains high despite taking standard medications. If your cholesterol isn't controlled well enough with current drugs, this trial may help you access an experimental treatment.
This study is checking how well people stick with taking bempedoic acid, a cholesterol-lowering medication, and how effective it is over time.
Hear when a new Cardiovascular trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.